(D) regional stockpiling of medical coun-
termeasures, including considerations of— 
(i) security of the stockpile; 
(ii) delivery planning; and 
(iii) legal dimensions of and obstacles 
to implementing such an architecture; 
(E) attribution; 
(F) response; 
(G) other elements that should be a com-
ponent of such an architecture; and 
(H) obstacles to implementing such an ar-
chitecture; 
(3) best practices for preparedness based on 
lessons learned from domestic efforts to address the 
above issues, and that may be applicable internation-
ally; 
(4) activities undertaken through the National 
Strategy for Countering Biological Threats and the 
International Health Regulations 2005, as well as 
other activities deemed relevant by the task force; 
and 
(5) the utility of working through existing inter-
national forums as a mechanism for distributing this 
information to the international community. 
VerDate Mar 15 2010 
03:58 Jun 11, 2010
Jkt 089200
PO 00000
Frm 00093
Fmt 6652
Sfmt 6201
E:\BILLS\H5498.IH
H5498
PWALKER on DSK8KYBLC1PROD with BILLS
(c) MEMBERSHIP.—Members of the task force shall 
include representatives from— 
(1) the Department of Homeland Security; 
(2) the Department of Health and Human 
Services, including the Centers for Disease Control 
and Prevention; 
(3) the Department of Agriculture; 
(4) the Department of Defense; 
(5) the Department of Justice; 
(6) the Department of State; 
(7) the United States Agency for International 
Development; 
(8) the Director of National Intelligence; 
(9) other Federal departments and agencies, as 
determined appropriate by the Secretary; and 
(10) other national biosecurity and biodefense 
stakeholders, including private sector, including the 
pharmaceutical industry and the biological labora-
tory community, as determined appropriate by the 
Secretary. 
(d) REPORT.—Not later than 18 months after the 
date of the enactment of this Act, the Secretary shall sub-
mit to the appropriate congressional committees a report 
on the findings of the task force established under this 
section. 
VerDate Mar 15 2010 
22:29 Jun 11, 2010
Jkt 089200
PO 00000
Frm 00094
Fmt 6652
Sfmt 6201
E:\BILLS\H5498.IH
H5498
PWALKER on DSK8KYBLC1PROD with BILLS
SEC. 404. BIOLOGICAL AND TOXIN WEAPONS CONVENTION. 
The Secretary of State shall— 
(1) promote confidence in effective implementa-
tion of and compliance with the Convention on the 
Prohibition of the Development, Production and 
Stockpiling of Bacteriological (Biological) and Toxin 
Weapons and on their Destruction (commonly re-
ferred to as the ‘‘Biological and Toxin Weapons 
Convention’’) by the States party to the Convention 
by promoting transparency with respect to legitimate 
activities and pursuing compliance diplomatically to 
address concerns; 
(2) promote universal membership in the Con-
vention; 
(3) develop an action plan for increasing inter-
national adherence to the Convention; and 
(4) ensure that United States participation in 
Convention meetings is broadly inclusive of rep-
resentatives of relevant Federal departments and 
agencies. 
Æ 
VerDate Mar 15 2010 
03:58 Jun 11, 2010
Jkt 089200
PO 00000
Frm 00095
Fmt 6652
Sfmt 6301
E:\BILLS\H5498.IH
H5498
PWALKER on DSK8KYBLC1PROD with BILLS